Abstract: Among other things, disclosed herein are compositions and methods for using human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum. Compositions may improve skin health. Methods may include applying human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum over a host or host area, such as skin or mucosa to minimize the presence of one or more pathogenic microbes, maximize therapeutic effects of one or more additional therapeutics, and/or improve health of a host or host area.

Abstract: An ocular needle guide for access into a space below a sclera of an eye comprises a housing. The housing has a contact surface and a needle guide surface. The contact surface defines a cavity within the housing. The contact surface extends at least partially along a contact plane. The needle guide surface extends about a needle axis to define a needle guide channel. The needle guide channel extends through the housing to an opening defined by the contact surface such that the needle guide channel opens to the cavity via the opening. The needle axis is substantially parallel to the contact plane. The contact surface is shaped such that when the ocular needle guide is positioned on the eye, a portion of the sclera is positioned within the cavity, and a surface of the eye contacts and takes a shape of the contact surface.

Abstract: Methods, non-transitory computer readable media, network traffic management apparatuses, central management devices, and network traffic management systems that control access to configuration data in a distributed system are illustrated. With this technology, a set of configuration data is stored in a first data structure and a corresponding set of configuration data is stored in a second data structure along with an encrypted digest value that was encrypted using a private key associated with a particular administrator role. The stored configuration data and/or newly received modifications to stored configuration data can be authenticated via a comparison of a digest value calculated using the configuration data compared to the stored encrypted digest value, which is decrypted with a stored public key corresponding to the administrator role.

Abstract: Methods, non-transitory computer readable media, network traffic management apparatuses, central management devices, and network traffic management systems that control access to configuration data in a distributed system are illustrated. With this technology, a set of configuration data is stored in a first data structure and a corresponding set of configuration data is stored in a second data structure along with an encrypted digest value that was encrypted using a private key associated with a particular administrator role. The stored configuration data and/or newly received modifications to stored configuration data can be authenticated via a comparison of a digest value calculated using the configuration data compared to the stored encrypted digest value, which is decrypted with a stored public key corresponding to the administrator role.

Abstract: Methods, non-transitory computer readable media, network traffic management apparatuses, central management devices, and network traffic management systems that control access to configuration data in a distributed system are illustrated. With this technology, a set of configuration data is stored in a first data structure and a corresponding set of configuration data is stored in a second data structure along with an encrypted digest value that was encrypted using a private key associated with a particular administrator role. The stored configuration data and/or newly received modifications to stored configuration data can be authenticated via a comparison of a digest value calculated using the configuration data compared to the stored encrypted digest value, which is decrypted with a stored public key corresponding to the administrator role.

Abstract: Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

Abstract: Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

Abstract: Among other things, disclosed herein are compositions and methods for using human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum. Compositions may improve skin health. Methods may include applying human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum over a host or host area, such as skin or mucosa to minimize the presence of one or more pathogenic microbes, maximize therapeutic effects of one or more additional therapeutics, and/or improve health of a host or host area. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic or another microbe to maximize growth and/or metabolites (e.g.

Abstract: Embodiments of the present disclosure provide systems and methods for managing access rights for a copy of an original digital document. The method performed by a server system includes receiving a request for generating a copy of an original document. The method includes performing an authorization of the request for generating the copy of the original document based on the access rights associated with the original document. Further, the method includes generating a copy document of the original document upon successful authorization. The method includes determining the access rights defined for the copy document in the original document. The method further includes transmitting the access rights to the copy document. The method includes sending the copy document with the access rights. The access rights set on the copy document facilitate the user to perform document-related operations on the copy document.

Abstract: A method for managing mainframe billable resources for a plurality of mainframe environments is provided. The method includes receiving a job file from a user, the job file including a batch file relating to a mainframe job and a mainframe task; identifying an override statement in the job file; determining, based on a result of the identifying, a mapping strategy according to a predetermined criterion, the mapping strategy relating to a mapping of the job file to a billing entity identifier; authorizing the job file based on the billing entity identifier and a logon identifier corresponding to the user; mapping the job file to the billing entity identifier based on the determined mapping strategy; recording, in a memory, information relating to the mapping; and executing, in a mainframe environment, the job file.

Abstract: Various exemplary drug delivery device sensing modules and methods of using drug delivery device sensing modules are provided. In general, a sensing module can be configured to be attached to a drug delivery device configured to deliver a drug. The drug delivery device can be any of a variety of types of drug delivery devices, such as a syringe, an injection device (e.g., an autoinjector, a jet injector, and an infusion pump), a nasal delivery device, and an inhaler. The sensing module can be configured to gather data for one or more parameters related to drug delivery and to transmit data indicative of the gathered data to an external source configured to analyze the data received from the sensing module.

Abstract: Methods and systems for performing exchange of data with third-party applications are described. The method includes receiving a request for performing document related operation on document using a third-party application. The method includes converting third-party application into containerized application using containerization mechanism. The method includes allocating virtual secured space to containerized application. The method includes encrypting document using public key of containerized application. The method includes providing encrypted document to containerized application that implements limitations on encrypted document. The method includes facilitating performance of document related operation on encrypted document to create updated document. The encrypted document is decrypted using private key of containerized application before performing document related operation on encrypted document.

Abstract: Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

Abstract: Methods and systems for encrypting shared information through its life cycle are described. The method includes receiving and storing a document. The method further includes encrypting document using a primary key. Further, the method includes receiving sharing request from current user of document for sharing document with a next user. The method includes, for each time the document is to be shared with next user in a series, generating a key for next user specified in sharing request. The method further includes encrypting document for next user using key generated for corresponding next user. Furthermore, the method includes binding access rights to document for authorizing request to access document by next user. The method includes sharing encrypted document with next user. Thereafter, the method includes receiving a request to access the document from the next user and providing the access to encrypted document meant for next user to next user.

Abstract: The present invention relates to a composition comprising a population of polysaccharide derivatives of a protein, wherein the protein is insulin or an insulin-like protein and the polysaccharide is anionic and comprises between 2 and 125 saccharide units, and wherein the population consists of substantially only N-terminal derivatives of the protein. Typically, the polysaccharide is PSA. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.

Abstract: A method for managing mainframe billable resources for a plurality of mainframe environments is provided. The method includes receiving a job file from a user, the job the including a batch file relating to a mainframe job and a mainframe task; identifying an override statement in the job file; determining, based on a result of the identifying, a mapping strategy according to a predetermined criterion, the mapping strategy relating to a mapping of the job file to a billing entity identifier; authorizing the job file based on the billing entity identifier and a logon identifier corresponding to the user; mapping the job tile to the billing entity identifier based on the determined mapping strategy; recording, in a memory, information relating to the mapping; and executing, in a mainframe environment, the job tile.

Abstract: Methods and systems for adaptive multi-factored geo-location based access rights management and enforcement for accessing location restricted data services are described. The method performed by server system includes receiving request to access a data service from a user device associated with a user. The method includes accessing geo-location information associated with the user upon receipt of request. The geo-location information includes geo-location data associated with the user device. The method includes generating geo-location signature associated with the user device, based on the geo-location information. The geo-location signature includes a plurality of location context identifiers. The method includes validating the user device when the geo-location signature and a geo-fence of the data service meet a matching threshold condition and transmitting a response message to the user device based on the validating step.

Abstract: Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

Abstract: Embodiments of the present disclosure provide systems and methods for managing access rights for a copy of an original digital document. The method performed by a server system includes receiving a request for generating a copy of an original document. The method includes performing an authorization of the request for generating the copy of the original document based on the access rights associated with the original document. Further, the method includes generating a copy document of the original document upon successful authorization. The method includes determining the access rights defined for the copy document in the original document. The method further includes transmitting the access rights to the copy document. The method includes sending the copy document with the access rights. The access rights set on the copy document facilitate the user to perform document-related operations on the copy document.

Abstract: Methods and systems for altering access rights set on a digital document, based on the triggering temporal events are described. The method performed by server system includes accessing access rights information associated with a digital document stored by the publisher in a database. The access rights information includes one or more access rights set on the digital document and access rights alteration rules. The method includes restricting access to the digital document for one or more recipients in response to receiving access requests from one or more recipients based, at least in part, on one or more access rights. The method includes monitoring occurrences of a plurality of the triggering temporal events based, at least in part, on a machine learning (ML) model. The method further includes altering one or more access rights set on the digital document based, at least in part, on the access rights alteration rules.